Clinical Trial Update: Formoterol-HFA 3-month Study in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 3]

View source ↗

Summary

This document reports a completed Phase 3 clinical trial of Formoterol-HFA in chronic obstructive pulmonary disease (COPD) patients. The sponsor is Chiesi Farma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Formoterol HFA (Formoterol)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED